Scientific Expertise

January 19, 2023

On-Demand

Dive into our podcast with Karina Eterovic, R&D Director for Oncology Diagnostics at Eurofins Viracor BioPharma (KS, USA). Karina gives her insight into the technological advancements made through the increased focus on precision oncology and explains the major challenges faced during drug development. 

December 8, 2022 11 am EST

On-Demand AVAILABLE  "Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond", presented by Dr. Mark Wissel, Director of R&D, Eurofins Viracor BioPharma.

November 11, 2022 11 am EST

On-Demand AVAILABLE "Next-Generation Sequencing Applications for Antiviral Drug Development", presented by Dr. Kirthi Kutambuka, Senior Research Scientist, Eurofins Viracor BioPharma

Check out the latest Eurofins BioPharma Newsletter

Eurofins Viracor BioPharma credited for role in Moderna COVE Vaccine Clinical Trial.

Check out this eBook detailing key methods in clinical vaccine development on BioAnalysisZone.com

Check out the latest BioPharma Newsletter

February 23, 2022 11 am EST

On-Demand AVAILABLE "Defining Specificity within the ELISpot Assay" Presented by TJ Beadnell, PhD, Scientific Manager, R&D. 

Gene therapy, cell therapy and vaccine research have led to an increased need to perform cellular immunity testing in a regulated environment to ensure the safety and efficacy of these treatments. The most common method for the measurement
of cellular immunity has been Enzyme-Linked Immunospot assays. However, there is a lack of regulatory guidance available discussing the recommendations for developing and validating these types of assays. Hence, the Global CRO Council has issued this white paper to provide a consensus on the different validation parameters required to support Enzyme-Linked Immunospot assays and a harmonized and consistent approach to Enzyme-Linked Immunospot validation among contract research organizations.